CorEvitas and Inovalon Leverage Advanced Analytics to Deliver A Holistic View of the Patient

WALTHAM, Mass., Sept. 21, 2021 /PRNewswire/ — CorEvitas, LLC , the gold-standard leader in longitudinal real-world data in autoimmune and inflammatory diseases, today announced that it has expanded its engagement with Inovalon’s (NASDAQ: INOV ) life sciences business unit specializing in data-driven healthcare analytics and strategic advisory services, to provide a holistic view of patients with rheumatoid arthritis or psoriasis.

Read the source article at PR Newswire
2021-09-21 16:00:59